TY - JOUR
T1 - Mandibular advancement device design
T2 - A systematic review on outcomes in obstructive sleep apnea treatment
AU - Venema, Julia A.M.Uniken
AU - Rosenmöller, Boudewijn R.A.M.
AU - de Vries, Nico
AU - de Lange, Jan
AU - Aarab, Ghizlane
AU - Lobbezoo, Frank
AU - Hoekema, Aarnoud
N1 - Funding Information:
NV is a member of the Medical Advisory Board of NightBalance, consultant of Philips Healthcare and Olympus and researcher for Inspire Medical Systems. JL receives research grants from KLS Martin and DePuy Synthes and receives speakers' bureau payments from Academic Centre for Dentistry Amsterdam. GA receives research grant from Sunstar Suisse SA and Vivisol-ResMed and is an unpaid member of the academic advisory board for Oral Function (Sunstar Suisse SA). FL receives research grants from Sunstar Suisse SA, SomnoMed, and Vivisol-ResMed and is an unpaid member of the academic advisory boards for GrindCare and for Oral Function (Sunstar Suisse SA). AH is a medical advisor for Airway Management Inc, SomnoMed, and Zephyr Sleep Technologies.
Funding Information:
NV is a member of the Medical Advisory Board of NightBalance, consultant of Philips Healthcare and Olympus and researcher for Inspire Medical Systems. JL receives research grants from KLS Martin and DePuy Synthes and receives speakers' bureau payments from Academic Centre for Dentistry Amsterdam . GA receives research grant from Sunstar Suisse SA and Vivisol-ResMed and is an unpaid member of the academic advisory board for Oral Function (Sunstar Suisse SA). FL receives research grants from Sunstar Suisse SA , SomnoMed , and Vivisol-ResMed and is an unpaid member of the academic advisory boards for GrindCare and for Oral Function (Sunstar Suisse SA). AH is a medical advisor for Airway Management Inc, SomnoMed, and Zephyr Sleep Technologies.
Publisher Copyright:
© 2021 The Authors
PY - 2021/12
Y1 - 2021/12
N2 - Obstructive Sleep Apnea (OSA) is often treated with Mandibular Advancement Devices (MADs). It is unclear whether particular design features are superior to others in terms of OSA alleviation. In order to facilitate clinical decision-making, this systematic review summarizes the objective and subjective outcomes of different available MAD designs. Studies comparing different MAD designs in OSA treatment were searched. After screening 1887 titles and abstracts, 20 original RCTs and six cohort studies were included. 14 articles were systematically reviewed in a meta-analysis. The decrease in AHI was significantly different between some of the MAD designs. The clinical relevance of the observed differences was however limited. Monoblock appliances performed more favorable, compared to bilateral thrust (effect size:-0.37; CI:-1.81 to 0.07). Midline traction appliances performed more favorable, compared to other designs. Custom appliances performed more favorable, compared to thermoplastic appliances (effect size:0.86; CI:-0.62 to 2.35). Furthermore, there were no clinically relevant differences between MAD designs in reduction of ESS, compliance, preference, side effects, and cost effectiveness. With respect to the included trials, presently there is not one superior custom MAD design in OSA treatment regarding the effect on AHI reduction, ESS improvement, compliance, preference, side effects, cost effectiveness, and other disease-related outcomes. We confirm custom MAD designs perform superior to thermoplastic MAD designs.
AB - Obstructive Sleep Apnea (OSA) is often treated with Mandibular Advancement Devices (MADs). It is unclear whether particular design features are superior to others in terms of OSA alleviation. In order to facilitate clinical decision-making, this systematic review summarizes the objective and subjective outcomes of different available MAD designs. Studies comparing different MAD designs in OSA treatment were searched. After screening 1887 titles and abstracts, 20 original RCTs and six cohort studies were included. 14 articles were systematically reviewed in a meta-analysis. The decrease in AHI was significantly different between some of the MAD designs. The clinical relevance of the observed differences was however limited. Monoblock appliances performed more favorable, compared to bilateral thrust (effect size:-0.37; CI:-1.81 to 0.07). Midline traction appliances performed more favorable, compared to other designs. Custom appliances performed more favorable, compared to thermoplastic appliances (effect size:0.86; CI:-0.62 to 2.35). Furthermore, there were no clinically relevant differences between MAD designs in reduction of ESS, compliance, preference, side effects, and cost effectiveness. With respect to the included trials, presently there is not one superior custom MAD design in OSA treatment regarding the effect on AHI reduction, ESS improvement, compliance, preference, side effects, cost effectiveness, and other disease-related outcomes. We confirm custom MAD designs perform superior to thermoplastic MAD designs.
KW - Bilateral thrust
KW - Mandibular advancement device (MAD)
KW - Meta-analysis
KW - Midline traction
KW - Monoblock
KW - Obstructive sleep apnea (OSA)
UR - http://www.scopus.com/inward/record.url?scp=85117145942&partnerID=8YFLogxK
U2 - 10.1016/j.smrv.2021.101557
DO - 10.1016/j.smrv.2021.101557
M3 - Review article
C2 - 34662769
AN - SCOPUS:85117145942
SN - 1087-0792
VL - 60
JO - Sleep Medicine Reviews
JF - Sleep Medicine Reviews
M1 - 101557
ER -